Details for New Drug Application (NDA): 040052
✉ Email this page to a colleague
The generic ingredient in THEOPHYLLINE is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 040052
Tradename: | THEOPHYLLINE |
Applicant: | Inwood Labs |
Ingredient: | theophylline |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040052
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 14, 1994 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 125MG | ||||
Approval Date: | Feb 14, 1994 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 14, 1994 | TE: | RLD: | No |
Complete Access Available with Subscription